BR9504456A - Compostos e processo para sua preparaçao seu uso e medicamento e processo para sua preparaçao - Google Patents

Compostos e processo para sua preparaçao seu uso e medicamento e processo para sua preparaçao

Info

Publication number: BR9504456A
Authority: BR; Brazil
Prior art keywords: preparation; medicine; compounds; alkoxy; formula
Prior art date: 1994-10-19

Application number

BR9504456A

Other languages

English (en)

Inventor

Manfred Dr Roesner

Uta-Maria Billhardt-Troughton

Reinhard Dr Kirsch

Joerg-Peter Dr Kleim

Christoph Dr Meichsner

Guenther Dr Ries

Irvin Dr Winkler

Original Assignee

Hoechst Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-10-19

Filing date

1995-10-19

Publication date

1997-05-20

1995-10-19 Application filed by Hoechst Ag filed Critical Hoechst Ag

1997-05-20 Publication of BR9504456A publication Critical patent/BR9504456A/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Virology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Dental Preparations (AREA)
Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
Medicinal Preparation (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Compounds Of Unknown Constitution (AREA)

BR9504456A 1994-10-19 1995-10-19 Compostos e processo para sua preparaçao seu uso e medicamento e processo para sua preparaçao BR9504456A (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE4437406A DE4437406A1 (de)	1994-10-19	1994-10-19	Chinoxaline, Verfahren zu ihrer Herstellung und ihre Verwendung

Publications (1)

Publication Number	Publication Date
BR9504456A true BR9504456A (pt)	1997-05-20

Family

ID=6531202

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BR9504456A BR9504456A (pt)	1994-10-19	1995-10-19	Compostos e processo para sua preparaçao seu uso e medicamento e processo para sua preparaçao

Country Status (28)

Country	Link
US (1)	US5723461A (pt)
EP (1)	EP0708093B1 (pt)
JP (1)	JPH08225544A (pt)
KR (1)	KR960014108A (pt)
CN (1)	CN1094930C (pt)
AT (1)	ATE198747T1 (pt)
AU (1)	AU708293B2 (pt)
BR (1)	BR9504456A (pt)
CA (1)	CA2160859A1 (pt)
CZ (1)	CZ271295A3 (pt)
DE (2)	DE4437406A1 (pt)
DK (1)	DK0708093T3 (pt)
ES (1)	ES2154311T3 (pt)
FI (1)	FI954946L (pt)
GR (1)	GR3035673T3 (pt)
HK (1)	HK1011988A1 (pt)
HR (1)	HRP950524B1 (pt)
HU (1)	HUT73485A (pt)
IL (1)	IL115641A0 (pt)
MY (1)	MY132057A (pt)
NO (1)	NO306615B1 (pt)
NZ (1)	NZ280258A (pt)
PL (1)	PL184860B1 (pt)
PT (1)	PT708093E (pt)
SI (1)	SI9500329A (pt)
SK (1)	SK128495A3 (pt)
TW (1)	TW328954B (pt)
ZA (1)	ZA958783B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6369057B1 (en) *	1991-04-15	2002-04-09	Aventis Pharma Deutschland Gmbh	Quinoxalines, processes for their preparation and their use
US6015800A (en) *	1997-09-03	2000-01-18	Warner-Lambert Company	Substituted quinoxaline-2-ones as glutamate receptor antagonists
WO1999025327A2 (en) *	1997-11-14	1999-05-27	Warner-Lambert Company	Small molecule intervention in hiv-1 replication
GB9901795D0 (en) *	1999-01-28	1999-03-17	Glaxo Group Ltd	Chemical compounds
GB9911887D0 (en) *	1999-05-21	1999-07-21	Glaxo Group Ltd	Methods and medicaments for post exposure prophylaxis of an hiv infection
WO2002087500A2 (en) *	2001-04-27	2002-11-07	Newbiotics, Inc.	Viral enzyme activated prototoxophores and use of same to treat viral infections
WO2005018531A2 (fr) *	2003-08-26	2005-03-03	'chemical Diversity Research Institute', Ltd.	Compositions pharmaceutiques, composes azo-heterocycliques et procedes de fabrication et d'utilisation correspondants
US7351709B2 (en) *	2004-06-09	2008-04-01	Wyeth	Estrogen receptor ligands
BR112014026703B1 (pt)	2012-04-24	2022-10-25	Vertex Pharmaceuticals Incorporated	Inibidores de dna-pk e seus usos, composição farmacêutica e seus usos, e método de sensibilização de uma célula
HRP20211855T1 (hr)	2013-03-12	2022-03-04	Vertex Pharmaceuticals Incorporated	Inhibitori dnk-pk
LT3424920T (lt)	2013-10-17	2020-08-10	Vertex Pharmaceuticals Incorporated	(s)-n-metil-8-(1-((2`-metil-[4,5`-bipirimidin]-6-il)amino)propan-2-il)chinolin-4-karboksamido ir jo deuterintų darinių, kaip dnr-pk inhibitorių, bendri kristalai
KR20190062485A (ko)	2016-09-27	2019-06-05	버텍스 파마슈티칼스 인코포레이티드	Dna-손상제 및 dna-pk 저해제의 조합을 사용한 암 치료 방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0509398B1 (de) *	1991-04-15	2001-09-19	Aventis Pharma Deutschland GmbH	Chinoxaline, Verfahren zu ihrer Herstellung und ihre Verwendung
DE4342024A1 (de) *	1993-12-09	1995-06-14	Hoechst Ag	Kombinationspräparate, enthaltend ein Chinoxalin und ein Nukleosid

1994
- 1994-10-19 DE DE4437406A patent/DE4437406A1/de not_active Withdrawn
1995
- 1995-10-12 DK DK95116094T patent/DK0708093T3/da active
- 1995-10-12 DE DE59508969T patent/DE59508969D1/de not_active Expired - Fee Related
- 1995-10-12 ES ES95116094T patent/ES2154311T3/es not_active Expired - Lifetime
- 1995-10-12 PT PT95116094T patent/PT708093E/pt unknown
- 1995-10-12 AT AT95116094T patent/ATE198747T1/de not_active IP Right Cessation
- 1995-10-12 EP EP95116094A patent/EP0708093B1/de not_active Expired - Lifetime
- 1995-10-15 IL IL11564195A patent/IL115641A0/xx unknown
- 1995-10-16 TW TW084110841A patent/TW328954B/zh active
- 1995-10-17 MY MYPI95003112A patent/MY132057A/en unknown
- 1995-10-17 CZ CZ952712A patent/CZ271295A3/cs unknown
- 1995-10-17 AU AU34316/95A patent/AU708293B2/en not_active Ceased
- 1995-10-17 FI FI954946A patent/FI954946L/fi unknown
- 1995-10-17 NZ NZ280258A patent/NZ280258A/en unknown
- 1995-10-17 SK SK1284-95A patent/SK128495A3/sk unknown
- 1995-10-17 US US08/544,290 patent/US5723461A/en not_active Expired - Fee Related
- 1995-10-18 HU HU9503005A patent/HUT73485A/hu unknown
- 1995-10-18 CN CN95120372A patent/CN1094930C/zh not_active Expired - Fee Related
- 1995-10-18 ZA ZA958783A patent/ZA958783B/xx unknown
- 1995-10-18 CA CA002160859A patent/CA2160859A1/en not_active Abandoned
- 1995-10-18 HR HR950524A patent/HRP950524B1/xx not_active IP Right Cessation
- 1995-10-18 KR KR1019950035876A patent/KR960014108A/ko not_active Abandoned
- 1995-10-18 NO NO954139A patent/NO306615B1/no not_active IP Right Cessation
- 1995-10-18 PL PL95311016A patent/PL184860B1/pl unknown
- 1995-10-19 SI SI9500329A patent/SI9500329A/sl unknown
- 1995-10-19 BR BR9504456A patent/BR9504456A/pt not_active IP Right Cessation
- 1995-10-19 JP JP7271019A patent/JPH08225544A/ja active Pending
1998
- 1998-12-12 HK HK98113241A patent/HK1011988A1/xx not_active IP Right Cessation
2001
- 2001-03-30 GR GR20010400523T patent/GR3035673T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
IL115641A0 (en)	1996-01-19
AU708293B2 (en)	1999-07-29
ZA958783B (en)	1996-05-09
MY132057A (en)	2007-09-28
TW328954B (en)	1998-04-01
HRP950524B1 (en)	2002-06-30
SI9500329A (en)	1996-04-30
CZ271295A3 (en)	1996-08-14
HK1011988A1 (en)	1999-07-23
JPH08225544A (ja)	1996-09-03
PT708093E (pt)	2001-06-29
FI954946L (fi)	1996-04-20
GR3035673T3 (en)	2001-06-29
NZ280258A (en)	1997-09-22
NO954139D0 (no)	1995-10-18
PL311016A1 (en)	1996-04-29
CN1094930C (zh)	2002-11-27
HRP950524A2 (en)	1997-10-31
CA2160859A1 (en)	1996-04-20
SK128495A3 (en)	1996-06-05
NO306615B1 (no)	1999-11-29
PL184860B1 (pl)	2003-01-31
EP0708093B1 (de)	2001-01-17
CN1135483A (zh)	1996-11-13
NO954139L (no)	1996-04-22
EP0708093A1 (de)	1996-04-24
ES2154311T3 (es)	2001-04-01
DE59508969D1 (de)	2001-02-22
FI954946A0 (fi)	1995-10-17
HU9503005D0 (en)	1995-12-28
HUT73485A (en)	1996-08-28
DK0708093T3 (da)	2001-04-30
ATE198747T1 (de)	2001-02-15
AU3431695A (en)	1996-05-02
KR960014108A (ko)	1996-05-22
US5723461A (en)	1998-03-03
DE4437406A1 (de)	1996-04-25

Similar Documents

Publication	Publication Date	Title
BR9504456A (pt)	1997-05-20	Compostos e processo para sua preparaçao seu uso e medicamento e processo para sua preparaçao
ZA918331B (en)	1992-07-29	Antimicrobial agents as well as substituted 2-cyclohexan-1-yl-amine derivatives and their preparation
KR890701566A (ko)	1989-12-21	헤테로사이클릭 화합물
BR9503536A (pt)	1996-06-04	Composto processo para sua preparação seu uso e composição farmacêutica
DE3882544D1 (de)	1993-09-02	Substituierte 3,4-dihydro-2h-benzopyrane, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen.
HRP960077B1 (en)	2001-06-30	Substituted benzenesulfonylureas and -thioureas, process for their preparation, their use as medicinal or diagnostic agent as well as medicaments containing them
PT99468A (pt)	1992-10-30	Processo para a preparacao de compostos cefem 7-actil-3-(carbamoiloxi substituido) com propriedades antibacterianas
FI923458A0 (fi)	1992-07-31	4,5-cykloalkano-3-benzazepin-7-ol- derivat och deras anvaendning.
TW216795B (en)	1993-12-01	3-substituted methyl-2,3-dihydroimidazo[1,2-c]quinazoline derivatives, the preparation and use thereof
DE3869144D1 (de)	1992-04-23	5-(3-alkyl-5-tert.butyl-4-hydroxyphenyl)-2-amino-6h-1,3,4-thiadiazine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung.
ATE15045T1 (de)	1985-09-15	Cephalosporinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
EP0487996B1 (de)	1998-07-22	3-substituierte Cephalosporine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
HUT76480A (en)	1997-09-29	Alkyl-5-methyl-sulphonyl-benzoyl-guanidine derivatives, process for the preparation thereof and pharmaceutical compositions containing them
AU683148B2 (en)	1997-10-30	Cyclohexane derivatives, process for their preparation, and the use of the compounds for the treatment of diseases
DE69002340D1 (de)	1993-09-02	Pyrimidin-derivate, 2-(4-(alpha-heteroaryl-alpha-aryl-(alpha-alkyl)-methoxy)-butyl)-1-piperazinyl) mit serotoninergischer wirkung.
ES8602797A1 (es)	1985-12-01	Procedimiento para preparar 11-piperazinil-5h-imidazo(2, 1-c) (1, 4) benzodiazepinas
DE69403896D1 (de)	1997-07-24	4-amino-2-(hetero)aryl-butanamide verwenbar als 5-ht1a-antagonisten
ES2063328T3 (es)	1995-01-01	Nuevo uso de naftoxazinas.
ES464729A1 (es)	1978-09-01	Un procedimiento para la preparacion de benzisotiazolonas amino-alquil sustituidas.
DE59104473D1 (de)	1995-03-16	Arzneimittel welche substituierte 2-Cyclohexen-1yl-amin-Derivate enthalten und ihre Verwendung zur Bekämpfung von Krankheiten.
ES459475A1 (es)	1978-04-16	Procedimiento para la preparacion de nuevas 9-alcohilamino- eritromicina.

Legal Events

Date	Code	Title	Description
2001-05-29	FB36	Technical and formal requirements: requirement - article 36 of industrial property law
2001-11-27	PC	Transfer	Free format text: AVENTIS PHARMA DEUTSCHLAND GMBH (DE)
2002-02-13	HJEG	Technical examination (opinion): technical examination (opinion) related to article 229 of industrial property law
2003-04-01	FG9A	Patent or certificate of addition granted
2010-04-13	B24C	Patent annual fee: request for for restoration	Free format text: REFERENTE 9A., 10A., 11A., 12A., 13A., E 14A. ANUIDADES.
2013-08-20	B21F	Lapse acc. art. 78, item iv - on non-payment of the annual fees in time	Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 2049 DE 13/04/2010 E COMPROVAR RECOLHIMENTO DA 15A , 16A , 17A E 18A ANUIDADES.